EHAB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EHAB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Enhabit's yield on cost for the quarter that ended in Dec. 2024 was 0.00.
The historical rank and industry rank for Enhabit's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Medical Care Facilities subindustry, Enhabit's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Enhabit's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Enhabit's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Enhabit is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Enhabit (NYSE:EHAB) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Enhabit's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeffrey Bolton | director | 1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901 |
Stuart M Mcguigan | director | 74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902 |
Erin Hoeflinger | director | 511 FALLVIEW COURT, SPRINGBORO OH 45066 |
Langham Ronald Leroy Jr | officer: EVP Clinical Excel. & Strategy | 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206 |
Shaw L Edward Jr | director | AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156 |
Barry P. Schochet | director | 100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011 |
Dylan C Black | officer: General Counsel and Secretary | 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206 |
Higdon Leo I Jr | director | 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203 |
Gregory S Rush | director | TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302 |
Tina L. Brown-stevenson | director | 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206 |
Tanya Renee Marion | officer: Chief Human Resources Officer | 6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206 |
Charles M Elson | director | 1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707 |
Barbara Ann Jacobsmeyer | director, officer: President and CEO | 2122 ACTON PARK WAY, BIRMINGHAM AL 35243 |
Yvonne M Curl | director | C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206 |
Maupin John E Jr D D S | director | 103 POWELL COURT SUITE 200, BRENTWOOD TN 37027 |
From GuruFocus
By GuruFocus News • 04-15-2025
By GuruFocus News • 12-12-2024
By GuruFocus News • 11-08-2024
By GuruFocus News • 04-17-2025
By Business Wire • 11-19-2024
By GuruFocus News • 02-15-2025
By GuruFocus News • 11-06-2024
By Business Wire • 03-11-2025
By Business Wire • 11-06-2024
By GuruFocus News • 03-07-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.